FDA Inspection 1095039 — Christus Spohn Hospital Corpus Christi
The FDA completed an inspection of Christus Spohn Hospital Corpus Christi on Jun 4, 2019 in Corpus Christi, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 4, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Corpus Christi, TX (United States)